
JACC: CardioOncology - Prognosis after Withdrawal of Cardioprotective Therapy in Patients with Improved Cancer Therapeutics-Related Cardiac Dysfunction
10/15/24 • 3 min
In this episode, Brian Halliday discusses a Korean study examining the outcomes of patients with cancer therapeutics-related cardiac dysfunction after withdrawing cardioprotective therapy. He highlights that while patients with an ejection fraction between 45 and 55% fared similarly regardless of therapy continuation, those with an ejection fraction below 45% experienced worse outcomes when they withdrew treatment, underscoring the need for further randomized trials to refine therapeutic approaches.
In this episode, Brian Halliday discusses a Korean study examining the outcomes of patients with cancer therapeutics-related cardiac dysfunction after withdrawing cardioprotective therapy. He highlights that while patients with an ejection fraction between 45 and 55% fared similarly regardless of therapy continuation, those with an ejection fraction below 45% experienced worse outcomes when they withdrew treatment, underscoring the need for further randomized trials to refine therapeutic approaches.
Previous Episode

JACC: Clinical Electrophysiology: Overcoming lead penetration failure in left bundle branch pacing
Emile Daoud, MD, Associate Editor of JACC: Clinical Electrophysiology discusses a recently published original research paper on overcoming lead penetration failure in left bundle branch pacing.
Next Episode

JACC: Cardiovasc Interventions - Failed Thrombus Aspiration and Reduced Myocardial Perfusion in Patients With STEMI and Large Thrombus Burden
Abdullah Al-Abcha, MD, social media editor of JACC: Cardiovascular Interventions, and Sung Gyun Ahn, MD, PhD, discuss a recently published original research paper reporting the outcomes of failed thrombus aspiration in patients with STEMI and large thrombus burden.
If you like this episode you’ll love
Episode Comments
Generate a badge
Get a badge for your website that links back to this episode
<a href="https://goodpods.com/podcasts/jacc-specialty-journals-416886/jacc-cardiooncology-prognosis-after-withdrawal-of-cardioprotective-the-76494748"> <img src="https://storage.googleapis.com/goodpods-images-bucket/badges/generic-badge-1.svg" alt="listen to jacc: cardiooncology - prognosis after withdrawal of cardioprotective therapy in patients with improved cancer therapeutics-related cardiac dysfunction on goodpods" style="width: 225px" /> </a>
Copy